Gentris Corp., of Morrisville, N.C., appointed Deborah Oronzio vice president of business development and marketing, and Sandra Sonnessa vice president of corporate development.
GlycoFi Inc., of Lebanon, N.H., appointed Richard Fisher vice president of research and product development.
HemoSense Inc., of San Jose, Calif., appointed Andrew Chisholm director of corporate accounts.
Icagen Inc., of Research Triangle Park, N.C., appointed Martin Simonetti to its board.
ImmuneRegen BioSciences Inc., of Scottsdale, Ariz., appointed Paul Carlton senior adviser to its bioterrorism preparedness advisory board.
InKine Pharmaceutical Co. Inc., of Blue Bell, Pa., appointed John Leone to its board.
Kai Pharmaceuticals Inc., of South San Francisco, appointed Kristine Ball vice president of finance and chief financial officer, and Stephen Harris vice president research.
Kalypsys Inc., of San Diego, appointed John McKearn CEO, and Philip Needleman and August Watanabe to its board.
Lexicon Genetics Inc., of The Woodlands, Texas, appointed Samuel Barker chairman.